Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
21 May, 2018 08:53 IST
Ashoka Buildcon gets extension in concession period from PWD
Source: IRIS | 11 Sep, 2017, 02.59PM
Comments  |  Post Comment

Ashoka Buildcon has got an extension in Concession Period by one year i.e. up to September 9, 2018 from Public Works Dept. of the State of Maharashtra (PWD) for its Project viz. four laning of long road sections from Ahmednagar to Ghodegaon and three laning from Ghodegaon to Wadala under Build-Operate-Transfer (BOT) basis on State Highway 60 (Project).

The toll notification is issued under the approved variation order by the State Government of Maharashtra. The total revenue for Q1 FY18 of the project is Rs 64.4 million.

The Nashik-based company is among the league of small companies that are making it big in the highway sector, which has seen a high number of toll-based build-operate-transfer projects in the past.

Shares of the company gained Rs 8.6, or 4.6%, to trade at Rs 195.60. The total volume of shares traded was 63,399 at the BSE (2.49 p.m., Monday).



Ashoka Buildcon Limited   (Q,N,C,F)*

Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Company Update
Ashok Leyland quarterly net surges 40% - 18-May-2018 16:38
Bank of Baroda enters into MoU with CCRL - 18-May-2018 16:31
Strides Shasun turns to loss in Jan-Mar quarter - 18-May-2018 15:32
Bajaj Auto quarterly net up 36.33% - 18-May-2018 15:24
3i Infotech Services forays into retail as new vertical - 18-May-2018 13:04
Shriram Transport Finance inks MoU with HPCL - 18-May-2018 12:49
Shriram Transport Finance inks MoU with HPCL - 18-May-2018 12:49
Airtel, Amazon India join hands to introduce a range of affordable 4G smartphones - 18-May-2018 12:11
L&T Construction wins orders worth Rs 15.04 bn - 18-May-2018 10:12
Glenmark Pharmaceuticals updates on clinical study of GBR 830 - 18-May-2018 10:08
R-Jio, Screenz partner to provide entertainment-based interactive platform - 18-May-2018 10:03
more...
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer